BIOCON
Quarterly Results Analysis [Sep2024]
BIOCON Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,590 Cr | ₹3,433 Cr | ₹3,917 Cr | ₹3,954 Cr | ₹3,462 Cr | ₹3,423 Cr | ₹3,774 Cr | ₹2,941 Cr |
Expenses | ₹2,905 Cr | ₹2,813 Cr | ₹3,001 Cr | ₹3,027 Cr | ₹2,721 Cr | ₹2,708 Cr | ₹2,777 Cr | ₹2,297 Cr |
Operating Income | ₹685 Cr | ₹620 Cr | ₹916 Cr | ₹927 Cr | ₹742 Cr | ₹714 Cr | ₹997 Cr | ₹644 Cr |
Other Income | ₹33 Cr | ₹1,135 Cr | ₹49 Cr | ₹566 Cr | ₹158 Cr | ₹94 Cr | ₹155 Cr | ₹79 Cr |
Interest | ₹226 Cr | ₹236 Cr | ₹227 Cr | ₹267 Cr | ₹248 Cr | ₹233 Cr | ₹249 Cr | ₹120 Cr |
Depreciation | ₹420 Cr | ₹405 Cr | ₹407 Cr | ₹415 Cr | ₹389 Cr | ₹358 Cr | ₹364 Cr | ₹301 Cr |
Profit Before Tax | ₹98 Cr | ₹1,146 Cr | ₹322 Cr | ₹832 Cr | ₹239 Cr | ₹217 Cr | ₹537 Cr | ₹30 Cr |
Profit After Tax | ₹27 Cr | ₹862 Cr | ₹226 Cr | ₹777 Cr | ₹197 Cr | ₹182 Cr | ₹455 Cr | ₹35 Cr |
EPS | ₹-0.13 | ₹5.49 | ₹1.13 | ₹5.50 | ₹1.05 | ₹0.84 | ₹2.61 | ₹-0.35 |
Industry Peers & Returns | 1W | 1M | 1Y |
BIOCON | -0.9% | 2.5% | 35.9% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 0.7% | 47.3% |
CIPLA | 0.3% | -1.8% | 19.6% |
DR REDDYS LABORATORIES | 6% | 11.8% | 20.3% |
ZYDUS LIFESCIENCES | -1.5% | -0.1% | 47% |
DIVIS LABORATORIES | -1.1% | -5.8% | 61.7% |
MANKIND PHARMA | 3.7% | 11.4% | 59.4% |
TORRENT PHARMACEUTICALS | 0.6% | 4.1% | 59.5% |
LUPIN | 3.3% | 2.9% | 75.9% |
BIOCON Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.59 % |
Y-o-Y | 3.70 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹3,590 Cr | 4.59 | |
Jun2024 | ₹3,433 Cr | -12.36 | |
Mar2024 | ₹3,917 Cr | -0.93 | |
Dec2023 | ₹3,954 Cr | 14.19 | |
Sep2023 | ₹3,462 Cr | 1.16 | |
Jun2023 | ₹3,423 Cr | -9.31 | |
Mar2023 | ₹3,774 Cr | 28.32 | |
Dec2022 | ₹2,941 Cr | - |
BIOCON Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 10.48 % |
Y-o-Y | -7.58 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹685 Cr | 10.48 | |
Jun2024 | ₹620 Cr | -32.26 | |
Mar2024 | ₹916 Cr | -1.18 | |
Dec2023 | ₹927 Cr | 24.97 | |
Sep2023 | ₹742 Cr | 3.81 | |
Jun2023 | ₹714 Cr | -28.37 | |
Mar2023 | ₹997 Cr | 54.79 | |
Dec2022 | ₹644 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 5.64 % |
Y-o-Y | -10.88 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 19.09% | 5.64 | |
Jun2024 | 18.07% | -22.71 | |
Mar2024 | 23.38% | -0.26 | |
Dec2023 | 23.44% | 9.43 | |
Sep2023 | 21.42% | 2.64 | |
Jun2023 | 20.87% | -21.04 | |
Mar2023 | 26.43% | 20.63 | |
Dec2022 | 21.91% | - |
BIOCON Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -96.86 % |
Y-o-Y | -86.24 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹27 Cr | -96.86 | |
Jun2024 | ₹862 Cr | 282.00 | |
Mar2024 | ₹226 Cr | -70.98 | |
Dec2023 | ₹777 Cr | 294.82 | |
Sep2023 | ₹197 Cr | 8.13 | |
Jun2023 | ₹182 Cr | -59.94 | |
Mar2023 | ₹455 Cr | 1,202.58 | |
Dec2022 | ₹35 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -97.01 % |
Y-o-Y | -86.82 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 0.75 % | -97.01 | |
Jun2024 | 25.1 % | 335.76 | |
Mar2024 | 5.76 % | -70.70 | |
Dec2023 | 19.66 % | 245.52 | |
Sep2023 | 5.69 % | 6.95 | |
Jun2023 | 5.32 % | -55.85 | |
Mar2023 | 12.05 % | 912.61 | |
Dec2022 | 1.19 % | - |
BIOCON Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹-0.13 | Negative | |
Jun2024 | ₹5.49 | 385.84 | |
Mar2024 | ₹1.13 | -79.45 | |
Dec2023 | ₹5.5 | 423.81 | |
Sep2023 | ₹1.05 | 25.00 | |
Jun2023 | ₹0.84 | -67.82 | |
Mar2023 | ₹2.61 | Positive | |
Dec2022 | ₹-0.35 | - |
You may also like the below Video Courses